Abstract
(2015). The indirect costs of systemic autoimmune diseases, systemic lupus erythematosus, systemic sclerosis and sarcoidosis: a summary of 2012 real-life data from the Social Insurance Institution in Poland. Expert Review of Pharmacoeconomics & Outcomes Research: Vol. 15, No. 4, pp. 667-673.

This publication has 8 references indexed in Scilit: